Track topics on Twitter Track topics that are important to you
ollaGenex Pharmaceuticals, Inc. is a pharmaceutical company focused on providing innovative medical therapies for the treatment of periodontitis and other pathologies characterized by the progressive degradation of the body's connective tissues. The Company's core technology involves inhibiting the activity of certain enzymes that degrade such connective tissues. The Company's first product, Periostat(R), is a prescription pharmaceutical capsule that was approved by the United States Food and Drug Administration (the "FDA") in September 1998 as an adjunct to scaling and root planning ("SRP"), the most prevalent non-surgical therapy for adult periodontitis, to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis. Adult periodontitis, a chronic disease characterized by theprogressive loss of attachment between the tooth root and the surrounding periodontal structures due to chronic progressive connective tissue degradation, may result in tooth loss if untreated..
41 University Drive
United States of America
Phone: 215 579 7388
Fax: 215 579 8577
CINCINNATI, OH / ACCESSWIRE / June 2, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "M Pharma"), is pleased to announce that it has engaged Camargo Pharmaceutic...
STA Pharmaceutical, a subsidiary of China-based WuXi AppTec, has merged its operations with the parent company’s pharmaceutical development services (PDS) division.
Sun Pharmaceutical Industries has announced the acquisition of a 15.91% stake in Krystal Biotech for $7m.
NewsCURE Pharmaceutical announces entrance into booming pharmaceutical cannabis industry.Contributed Author:
CINCINNATI, OH / ACCESSWIRE / August 1, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2) ("M Pharma"), announces today that to better align with its expertise in the healthcare field...
This innovation is driving profits, competition, and market growth: Singapore's pharmaceutical industry is estimated to be worth more than USD 800 million by 2020. In a recent article titled Top 1...
Uppsala, Sweden, 2017-09-11 22:05 CEST (GLOBE NEWSWIRE) -- Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, hereby issues a no...
Pharmaceutical Development Group (PDG) provides pharmaceutical regulatory consulting to firms located around the world.
Cetirizine Hydrochloride Syrup
Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...
Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...
Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative medicines. Pharmaceutical co-crystals, formed by an active pharmaceutical substance (API) and a co-crys...
Drug therapy plays a critical role in most chronic diseases. Effectiveness of pharmaceutical care services in the improvement of clinical, social, or economic outcomes has been scientifically proven t...
Due to a lack of pharmaceutical care (PC)-specific measures for health-related quality of life, a novel generic questionnaire "Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality o...
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...
The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...
The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...
The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.
CollaGenex Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on providing innovative medical therapies for dermatological diseases.
ollaGenex Pharmaceuticals, Inc. is a pharmaceutical company focused on providing innovative medical therapies for the treatment of periodontitis and other pathologies characterized by the progre...
Dr. Beardsley has served as Kereos’ President and CEO, and as a board member, since January 2003. Prior to joining Kereos, Dr. Beardsley was acting CEO and a Board member of Metaphore Pharmaceutical...
Pharmaceutical Online, the pharmaceutical manufacturing industry’s leading Web site. Our online community serves the product-sourcing and information-seeking needs of pharmaceutical professionals wo...
Cypress Pharmaceutical, Inc., founded in 1993, is a specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to leading...
We have published hundreds of CollaGenex Pharmaceutical news stories on BioPortfolio along with dozens of CollaGenex Pharmaceutical Clinical Trials and PubMed Articles about CollaGenex Pharmaceutical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CollaGenex Pharmaceutical Companies in our database. You can also find out about relevant CollaGenex Pharmaceutical Drugs and Medications on this site too.